Cassava Sciences Inc (NQ: SAVA )
10.96
+1.12
(+11.36%)
Streaming Delayed Price
Updated: 11:08 AM EDT, Jul 9, 2024
Add to My Watchlist
All News about Cassava Sciences Inc
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/july/mmc/mmc-stats-0705.png?sfvrsn=1140aa06_0)
![](https://cdn.benzinga.com/files/images/story/2023/07/05/sava.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/738621/alphataumedical.jpg)
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
New Research Shows Simufilam Suppresses Overactive mTOR
June 27, 2023
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/732367/doctors-white-coat-healthcare-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/09/sava-stock-1600.jpg)
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
![](https://investorplace.com/wp-content/uploads/2018/09/biotech-stocks.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/risk-high-risk.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/05/10/image15.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
![](https://cdn.benzinga.com/files/healthcare_8.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/asan_asana1600.png)
![](https://investorplace.com/wp-content/uploads/2022/04/etsy-1600-1-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2023/02/short-squeeze-stocks1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1938998998-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/03/09/image-asana.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Stock_Market_Broker_Analyzing_Graphs_On_Multiple_Computer_Screens._Photo_by_Andrey_Popov_on_Shutterstock_6.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/08/artificial-intelligence-gd1d7965e2_1920.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/b3eb579e-cf3b-48b9-ab0e-ae8c85caaf29/small/cassava-2-png.png)
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2019/07/drug_stocks1600.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.